Clinical Trials

342 enrolled

Sarcoma

Rhabdomyosarcoma

NCT06630273 2026-03-10

(CAN-IMPACT-IO

Not yet recruiting

120 enrolled

Tumor-Agnostic

Carcinoma

NCT07022678 2026-02-27

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Other hematologic neoplasm

556 enrolled

Leukemia, Myeloid, Acute

NCT07297667 2026-02-13

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Phase 1 Not yet recruiting

30 enrolled

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07341191 2026-02-12

Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

40 enrolled

Lymphoid

Recurrence, Lymphoma, Mantle-Cell

NCT07393555 2026-02-06

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

117 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07390435 2026-02-05

Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

Not yet recruiting

1,000 enrolled

Tumor-Agnostic

Neoplasms

NCT05411237 2026-01-23

Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma

130 enrolled

Sarcoma

AIDS-related Kaposi sarcoma, Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

NCT05797662 2026-01-23

A Study of Propranolol to Treat Kaposi Sarcoma

25 enrolled

Sarcoma

Sarcoma, Kaposi

NCT07203053 2026-01-22

START-lung

48 enrolled

Extensive Stage Lung Small Cell Cancer

NCT07347977 2026-01-16

LidCRM

1,400 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Recurrence

NCT06858501 2025-12-31

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

84 enrolled

CNS

Ganglioneuroblastoma

NCT07278739 2025-12-12

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

1,020 enrolled

Other solid neoplasm

Malignant Solid Neoplasm

NCT07068074 2025-11-13

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

428 enrolled

Dermatologic

Melanoma

NCT07085728 2025-08-22

Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients With Kidney Failure

74 enrolled

Plasma cell

Multiple Myeloma

NCT07122492 2025-08-14

FoRtitude

800 enrolled

Breast

Breast Cancer Survivor

NCT07107529 2025-08-12

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

150 enrolled

Plasma cell

Multiple Myeloma

NCT07040280 2025-06-27

Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma

120 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT06786585 2025-05-30

Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

Not yet recruiting

600 enrolled

Breast

Breast Neoplasms

NCT06938490 2025-04-22

COLAP-D3